(Q30441667)

21 June 2017

title

Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease (English)

1 reference

21 June 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

2 November 2022

author name string

Bennett JP Jr

2

1 reference

21 June 2017

D. Orosz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699767

2 November 2022

J. P. Bennett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699767

2 November 2022

language of work or name

English

0 references

publication date

1 July 1990

1 reference

21 June 2017

17 July 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1699767

full work available at URL

2 November 2022

https://api.elsevier.com/content/article/PII:001429999090049C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

https://api.elsevier.com/content/article/PII:001429999090049C?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

European Journal of Pharmacology

2 November 2022

published in

1 reference

21 June 2017

volume

182

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

509-514

1 reference

Substance P-dopamine relationship in the rat substantia nigra: a light and electron microscopy study of double immunocytochemically labeled materials

21 June 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Changes in 3H-substance P receptor binding in the rat brain after kainic acid lesion of the corpus striatum

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Metalloendopeptidase (EC 3.4.24.11) but not angiotensin converting enzyme is involved in the inactivation of substance P by synaptic membranes of the rat substantia nigra

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Visualization of rat brain receptors for the neuropeptide, substance P.

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats.

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Biochemical characterization and autoradiographic localization of central substance P receptors using [125I]physalaemin

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(90)90049-C

2 November 2022

Identifiers

1 reference

21 June 2017

1 reference